Telspade Beta 50 Tablet ER
Marketer
Meraki Health
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Telspade Beta 50 Tablet ER
Betapace 50 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use enhances survival rates following a heart attack. Consistent blood levels are achieved by taking this medication with food at the same time daily, as prescribed by your physician. Continue treatment as directed; cessation, even with well-being, is inadvisable as hypertension often presents asymptomatically. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, complement this therapy. Adhere to your doctor's guidance. Potential side effects encompass headache, weakness, lightheadedness, hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood glucose, kidney function, and electrolyte levels may be required. Inform your doctor of any kidney or liver conditions before starting treatment. Pregnant or breastfeeding individuals should seek medical consultation before use. Disclose all medications, particularly those for hypertension or heart disease.
Uses of Telspade Beta 50 Tablet ER
Managing elevated blood pressure
Major Benefits of Telspade Beta 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Telspade Beta 50 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Telspade Beta 50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telspade Beta 50 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Telspade Beta 50 Tablet ER whole; avoid chewing, crushing, or breaking it. Consume this extended-release tablet with a meal.
How Telspade Beta 50 Tablet ER works:
Telspade Beta 50 Extended-Release tablets contain a dual-action formulation of telmisartan and metoprolol succinate, both effective in reducing blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telspade Beta 50 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telspade Beta 50 tablets present a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known dangers. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telspade Beta 50 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Telspade Beta 50 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Telspade Beta 50 tablets are considered safe for use in individuals with impaired kidney function. No dosage modification is necessary for this medication in such patients.
LiverCAUTION
Patients with hepatic impairment should use Telspade Beta 50 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telspade Beta 50 Tablet ER :
Should you forget a Telspade Beta 50 Tablet ER dose, take it immediately if you remember. But, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Telspade Beta 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Heart |





